Ecofibre | Les Charges D'Exploitation



Operating Expenses Changement Date
Alaunos Therapeutics USD 759K 391K 2024-12
Avita Medical AUD 28.36M 2.44M 2024-12
Clinuvel Pharmaceuticals AUD 20.71M 2.35M 2024-06
Dianthus Therapeutics USD 33.24M 1.17M 2024-12
Ecofibre AUD 12.31M 44.07M 2024-06
Genetic Signatures AUD 16.39M 689K 2024-06
Ionis Pharmaceuticals USD 337.4M 54.93M 2024-12
Medical Developments International AUD 10.35M 17.73M 2024-06
Neuren Pharmaceuticals AUD 17.41M 2.86M 2024-12
Organon & Co USD 1.46B 88M 2024-12
Paradigm Biopharmaceuticals AUD 14.97M 35.18M 2024-06
PYC Therapeutics AUD 18.29M 5.76M 2024-06
Starpharma Holdings AUD 4.43M 4.63M 2024-06
Tectonic Therapeutic USD 13.99M 5.65M 2024-12
Telix Pharmaceuticals AUD 321.98M 62.28M 2024-06
Viatris USD 3.55B 84.2M 2024-12
Xeris Pharmaceuticals USD 58.42M 8.74M 2024-12



Ecofibre Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.